Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Joshua M. Cohen · SciRah

Researcher profile · Semantic Scholar

Joshua M. Cohen

Share profile

Joshua M. Cohen — researcher profile on SciRah

h-index: 20
Works: 60
Citations: 1,509

Most-cited papers

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
M. Ferrari, H. Diener, X. Ning, M. Galić +8 more
2019The Lancet333 citations
Semantic Scholar
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
S. Silberstein, Joshua M. Cohen, M. Seminerio, Rong-Hua Yang +2 more
2020The Journal of Headache and Pain119 citations Open access
Semantic Scholar
Functional Deficits After Intraneural Injection During Interscalene Block
Joshua M. Cohen, A. Gray
2010Regional anesthesia and pain medicine101 citations
Semantic Scholar
Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine
Stephen D. Silberstein, Lu-Lu Lee, Kavita Gandhi, T. Fitzgerald +2 more
2018Headache77 citations
Semantic Scholar
Migraine and Vestibular Symptoms—Identifying Clinical Features That Predict “Vestibular Migraine”
Joshua M. Cohen, M. Bigal, L. Newman
2011Headache70 citations
Semantic Scholar
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
R. Lipton, Joshua M. Cohen, M. Galić, M. Seminerio +5 more
2021Headache53 citations Open access
Semantic Scholar
Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine
D. Buse, M. S. Yugrakh, Lu-Lu Lee, Jvawnna D Bell +2 more
2020Journal of Managed Care & Specialty Pharmacy48 citations Open access
Semantic Scholar
Fremanezumab as Add‐On Treatment for Patients Treated With Other Migraine Preventive Medicines
Joshua M. Cohen, D. Dodick, Rong-Hua Yang, L. Newman +3 more
2017Headache48 citations
Semantic Scholar
Physician and patient preferences for dosing options in migraine prevention
R. Cowan, Joshua M. Cohen, Erik Rosenman, R. Iyer
2019The Journal of Headache and Pain46 citations Open access
Semantic Scholar
Long-term safety, tolerability, and efficacy of fremanezumab in migraine
P. Goadsby, S. Silberstein, Paul P. Yeung, Joshua M. Cohen +3 more
2020Neurology42 citations Open access
Semantic Scholar
Immunogenicity of biologic therapies for migraine: a review of current evidence
Joshua M. Cohen, X. Ning, Y. Kessler, M. Rasamoelisolo +5 more
2021The Journal of Headache and Pain38 citations Open access
Semantic Scholar
Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study
M. Ashina, Joshua M. Cohen, M. Galić, Verena Ramirez Campos +5 more
2021The Journal of Headache and Pain32 citations Open access
Semantic Scholar
Combined preoperative femoral and sciatic nerve blockade improves analgesia after anterior cruciate ligament reconstruction: a randomized controlled clinical trial.
M. Harbell, Joshua M. Cohen, K. Kolodzie, M. Behrends +4 more
2016Journal of clinical anesthesia31 citations
Semantic Scholar
Effect of fremanezumab on quality of life and productivity in patients with chronic migraine
R. Lipton, Joshua M. Cohen, S. Gandhi, Rong-Hua Yang +2 more
2020Neurology28 citations Open access
Semantic Scholar
Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine
R. Lipton, Lu-Lu Lee, Nicolas P. Saikali, Jvawnna D Bell +1 more
2020Journal of Managed Care & Specialty Pharmacy28 citations Open access
Semantic Scholar
Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
P. McAllister, L. Lamerato, L. Krasenbaum, Joshua M. Cohen +6 more
2021The Journal of Headache and Pain27 citations Open access
Semantic Scholar
No “Wearing‐Off Effect” Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study
A. Blumenfeld, Darko M. Stevanovic, Mario Ortega, Joshua M. Cohen +4 more
2020Headache27 citations Open access
Semantic Scholar
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Stephanie J. Nahas, S. Naegel, Joshua M. Cohen, X. Ning +6 more
2021The Journal of Headache and Pain26 citations Open access
Semantic Scholar
State and institutional policies on in-state resident tuition and financial aid for undocumented students: Examining constraints and opportunities
Gabriel R. Serna, Joshua M. Cohen, D. H. Nguyen
201722 citations Open access
Semantic Scholar
Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
R. Lipton, Joshua M. Cohen, K. Bibeau, M. Galić +4 more
2020Headache21 citations Open access
Semantic Scholar
The ABMS MOC Part III Examination: Value, Concerns, and Alternative Formats
R. Hawkins, Mira B Irons, Catherine M. Welcher, M. Pouwels +13 more
2016Academic medicine : journal of the Association of American Medical Colleges20 citations Open access
Semantic Scholar
Development and Validation of an Assessment of Regional Anesthesia Ultrasound Interpretation Skills
G. Woodworth, P. Carney, Joshua M. Cohen, S. Kopp +6 more
2015Regional anesthesia and pain medicine20 citations
Semantic Scholar
Differentiation between MK-801- and apomorphine-induced stereotyped behaviors in mice.
Ana Hitri, David A. O'Connor, Joshua M. Cohen, David J. Keuler +1 more
1993Clinical neuropharmacology20 citations
Semantic Scholar
Headache and Dizziness: How to Differentiate Vestibular Migraine from Other Conditions
Joshua M. Cohen, Carlos A Escasena
2015Current Pain and Headache Reports19 citations
Semantic Scholar
PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine.
M. Ashina, F. Amin, Pinar Kokturk, Joshua M. Cohen +4 more
2021Pain Management18 citations Open access
Semantic Scholar
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study
D. Buse, S. Gandhi, Joshua M. Cohen, V. Ramirez-Campos +3 more
2020The Journal of Headache and Pain18 citations Open access
Semantic Scholar
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
A. Maassenvandenbrink, G. Terwindt, Joshua M. Cohen, S. Barash +4 more
2021The Journal of Headache and Pain16 citations Open access
Semantic Scholar
Young Adults With Headaches: The Transition From Adolescents to Adults
H. O'Brien, Joshua M. Cohen
2015Headache14 citations
Semantic Scholar
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response
L. Pazdera, Joshua M. Cohen, X. Ning, Verena Ramirez Campos +2 more
2021Cephalalgia12 citations Open access
Semantic Scholar
Fremanezumab for the preventive treatment of migraine
S. Silberstein, Joshua M. Cohen, Paul P. Yeung
2019Expert Opinion on Biological Therapy12 citations
Semantic Scholar
Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review
Christopher Rhyne, Joshua M. Cohen, M. Seminerio, K. Carr +1 more
2023Medicine11 citations Open access
Semantic Scholar
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
Hans-Christoph Diener, P. McAllister, T. Jürgens, Y. Kessler +5 more
2022Cephalalgia11 citations Open access
Semantic Scholar
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
S. Silberstein, Joshua M. Cohen, Rong-Hua Yang, S. Gandhi +3 more
2021The Journal of Headache and Pain11 citations Open access
Semantic Scholar
A glycinergic intervention potentiates the antiseizure efficacies of MK-801, flurazepam, and carbamazepine
Deborah O. Norris, J. Mastropaolo, David A. O'Connor, Joshua M. Cohen +1 more
1994Neurochemical Research11 citations
Semantic Scholar
Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments
George R. Nissan, Richard Kim, Joshua M. Cohen, M. Seminerio +3 more
2022Journal of Clinical Medicine10 citations Open access
Semantic Scholar
Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine
D. Friedman, Joshua M. Cohen
2020Emerging Topics in Life Sciences10 citations Open access
Semantic Scholar
Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial
E. Spierings, M. Kärppä, X. Ning, Joshua M. Cohen +3 more
2021The Journal of Headache and Pain9 citations Open access
Semantic Scholar
Epidemiology of cluster headache
Susan W. Broner, Joshua M. Cohen
2009Current pain and headache reports9 citations
Semantic Scholar
The Positive Impact of Fremanezumab on Work Productivity and Activity Impairment in Patients with Chronic Migraine (S32.007)
R. Lipton, S. Gandhi, T. Fitzgerald, Paul P. Yeung +3 more
2018Neurology8 citations
Semantic Scholar
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid
M. Ferrari, K. M. W. Zuurbier, S. Barash, X. Ning +1 more
2022Headache7 citations Open access
Semantic Scholar
Burden of migraine in Brazil: A cross‐sectional real‐world study
M. N. Souza, Joshua M. Cohen, T. Piha, R. Ribalov +4 more
2022Headache5 citations
Semantic Scholar
Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
M. Ashina, Joshua M. Cohen, S. Gandhi, Evelyn Du
2021Headache5 citations Open access
Semantic Scholar
Preoperative Sciatic and Femoral Nerve Blocks for Anterior CruciateLigament Reconstruction: A Retrospective Analysis
Joshua M. Cohen, K. Kolodzie, Sujay Shah, P. Aleshi
20144 citations
Semantic Scholar
Reversion of Patients With Chronic Migraine to an Episodic Migraine Classification With Fremanezumab Treatment (P4.112)
Joshua M. Cohen, K. Bibeau, M. Galić, M. Seminerio +3 more
2018Neurology3 citations
Semantic Scholar
Letter to the editor regarding “Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database”
Y. Kessler, X. Ning, Joshua M. Cohen
2021Cephalalgia2 citations
Semantic Scholar
State expenditures to public higher education and regional funding norms: a panel data analysis
Gabriel R. Serna, Joshua M. Cohen
2020International Journal of Quantitative Research in Education2 citations
Semantic Scholar
The Impact of Fremanezumab on Headache-Related Disability in Patients with Episodic Migraine using the Migraine Disability Assessment (P4.095)
P. Winner, T. Fitzgerald, S. Gandhi, Paul P. Yeung +3 more
2018Neurology2 citations
Semantic Scholar
A Case of Barotrauma‐Induced Post‐Traumatic Headache With a Cluster Headache Phenotype
Laura Charney, A. Rubino, Joshua M. Cohen
2016Headache2 citations
Semantic Scholar
Adverse events reported to FDA adverse event reporting system for long-acting injectable buprenorphine during the first 18 months postlaunch.
Brian J. Dawson, Michael P. Frost, N. R. Budilovsky-Kelley, G. Fiore +3 more
2026Journal of substance use and addiction treatment1 citations Open access
Semantic Scholar
The Impact of Headache Free Days on Quality of Life and Costs Among People with Migraine with ≥4 Headache Days in the Past Month (P3.139)
Jvawnna D Bell, Lu-Lu Lee, T. Fitzgerald, Joshua M. Cohen
2018Neurology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

X. Ning×11
Invite
X. Ning — researcher profile on SciRah
Rong-Hua Yang×11
Invite
Rong-Hua Yang — researcher profile on SciRah
M. Seminerio×8
Invite
M. Seminerio — researcher profile on SciRah
Verena Ramirez Campos×8
Invite
Verena Ramirez Campos — researcher profile on SciRah

×6

Invite

M. Galić — researcher profile on SciRah

Invite

R. Lipton — researcher profile on SciRah

Paul P. Yeung×6

Invite

Paul P. Yeung — researcher profile on SciRah

Invite

S. Gandhi — researcher profile on SciRah

S. Silberstein×5

Invite

S. Silberstein — researcher profile on SciRah

Invite

Lu-Lu Lee — researcher profile on SciRah

L. Krasenbaum×5

Invite

L. Krasenbaum — researcher profile on SciRah

Invite

M. Ashina — researcher profile on SciRah